Literature DB >> 8942547

Gastric adenocarcinoma in patients 40 years of age or younger.

C P Theuer1, C de Virgilio, G Keese, S French, T Arnell, J Tolmos, S Klein, W Powers, T Oh, B E Stabile.   

Abstract

BACKGROUND: Gastric adenocarcinoma is considered a disease of the middle aged and elderly and has been infrequently reported in patients under 40 years of age. The purpose of this study was to determine the proportion of young patients diagnosed with gastric adenocarcinoma and to compare the demographic, clinical and pathologic features of younger and older patients with gastric adenocarcinoma.
METHODS: A retrospective cohort study using tumor registry records of all patients with gastric adenocarcinoma diagnosed from 1982 through 1996 at a public teaching hospital. Demographic, clinical, and pathologic comparisons were made between patients younger than 41 years of age and race- and sex-matched older patients with gastric adenocarcinoma.
RESULTS: Thirty of 203 (15%) cases of gastric adenocarcinoma were diagnosed in patients less than 41 years (range 23 to 40). Male to female ratio was 1:1. Young patients were more likely to be black (33% versus 17%, P = 0.04) Both younger and older patients presented with advanced disease, with nearly half of each group having metastases. Twelve of 29 (41%) younger patients were operated on without a histologic diagnosis of gastric adenocarcinoma in contrast to only 1 older patient (P < 0.001). One of 30 (3%) young patients is alive 39 months following gastrectomy. Twenty patients died and the remaining 9 were lost to follow-up, all with known residual or recurrent disease. Six-month survival of young patients (23%) was less than older patients (42%) (P = 0.14). Young patients were more likely to have diffuse histology (80% versus 55%, P = 0.12). Overt infection with Helicobacter pylori was uncommon in both groups.
CONCLUSIONS: Young patients accounted for an unusually high proportion of patients with gastric adenocarcinoma diagnosed at our public teaching hospital. Young patients were significantly more likely to be black and less likely to have an accurate preoperative histologic diagnosis. Both young and older patients presented with advanced disease and had poor survival. Young patients were more likely to have diffuse histology and had poorer 6-month survival, suggesting a more aggressive variety of the disease in this group.

Entities:  

Mesh:

Year:  1996        PMID: 8942547     DOI: 10.1016/S0002-9610(96)00223-1

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  44 in total

1.  Descriptive epidemiology of gastric adenocarcinoma in the state of Texas by ethnicity: Hispanic versus White non-Hispanic.

Authors:  Babak Rajabi; Javier C Corral; Nawar Hakim; Zuber D Mulla
Journal:  Gastric Cancer       Date:  2012-01-18       Impact factor: 7.370

2.  Cancer gene profiling explores the possible precision medicine for diffuse-type gastric adenocarcinoma.

Authors:  Marin Ishikawa; Hideyuki Hayashi; Naoya Sakamoto; Shinya Tanaka; Hiroshi Nishihara
Journal:  Med Oncol       Date:  2019-11-25       Impact factor: 3.064

3.  Clinicopathological characteristics and prognostic analysis of gastric cancer in the young adult in China.

Authors:  Miao-zhen Qiu; Zhi-qiang Wang; Dong-sheng Zhang; Hui-yan Luo; Zhi-wei Zhou; Feng-hua Wang; Yu-hong Li; Wen-qi Jiang; Rui-hua Xu
Journal:  Tumour Biol       Date:  2010-12-23

4.  Survival of young patients after gastrectomy for gastric cancer.

Authors:  Osvaldo Llanos; Jean Michel Butte; Fernando Crovari; Ignacio Duarte; Sergio Guzmán
Journal:  World J Surg       Date:  2006-01       Impact factor: 3.352

5.  Analysis of demographic characteristics in 3242 young age gastric cancer patients in Korea.

Authors:  Hye Won Chung; Sung Hoon Noh; Jong-Baeck Lim
Journal:  World J Gastroenterol       Date:  2010-01-14       Impact factor: 5.742

6.  Carcinoma of the stomach: A review of epidemiology, pathogenesis, molecular genetics and chemoprevention.

Authors:  Siddavaram Nagini
Journal:  World J Gastrointest Oncol       Date:  2012-07-15

7.  Clinicopathological evaluation of Sox10 expression in diffuse-type gastric adenocarcinoma.

Authors:  Marin Kato; Hiroshi Nishihara; Hideyuki Hayashi; Taichi Kimura; Yusuke Ishida; Lei Wang; Masumi Tsuda; Mishie Ann Tanino; Shinya Tanaka
Journal:  Med Oncol       Date:  2016-12-10       Impact factor: 3.064

8.  Cadherin-catenin adhesion system and mucin expression: a comparison between young and older patients with gastric carcinoma.

Authors:  Edaise M Silva; Maria D Begnami; José Humberto T G Fregnani; Adriane G Pelosof; Claudia Zitron; André L Montagnini; Fernando Augusto Soares
Journal:  Gastric Cancer       Date:  2008-09-30       Impact factor: 7.370

9.  IkappaBalpha polymorphism at promoter region (rs2233408) influences the susceptibility of gastric cancer in Chinese.

Authors:  Shiyan Wang; Linwei Tian; Zhirong Zeng; Mingdong Zhang; Kaichun Wu; Minhu Chen; Daiming Fan; Pinjin Hu; Joseph J Y Sung; Jun Yu
Journal:  BMC Gastroenterol       Date:  2010-02-05       Impact factor: 3.067

10.  DNA copy number changes in young gastric cancer patients with special reference to chromosome 19.

Authors:  A Varis; B van Rees; M Weterman; A Ristimäki; J Offerhaus; S Knuutila
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.